Associated Papers
Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis.
Wen S et al.
Nature Genetics, 2025
39948438 (PubMed )
Supplement: 41588_2025_2085_MOESM4_ESM.xlsx › ST22
Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2.
McCarthy-Leo CE et al.
Plos Genetics, 2024
39146382 (PubMed )
Supplement: pgen.1011375.s010.xlsx › All_Assays
The association of three DNA repair genes polymorphisms on the frequency of chromosomal alterations detected by fluorescence in situ hybridization.
Santiago F et al.
International Archives of Occupational and Environmental Health, 2021
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
Bayram S et al.
Gene, 2013
CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Bayram S et al.
Cancer Epidemiology, 2012
Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.
Myszka A et al.
Journal of Applied Genetics, 2011
Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer.
Skasko E et al.
Onkologie, 2009
Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer.
Adjadj E et al.
The Lancet. Oncology, 2009
CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
Szymanska-Pasternak J et al.
Gynecologic Oncology, 2006
Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hereditary Cancer in Clinical Practice, 2006
Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland.
Kwiatkowska E et al.
Neoplasma, 2006
Low frequency of CHEK2 mutations in familial pancreatic cancer.
Bartsch DK et al.
Familial Cancer, 2006
CHEK2 is a multiorgan cancer susceptibility gene.
Cybulski C et al.
American Journal of Human Genetics, 2004
A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cybulski C et al.
Cancer Research, 2004
Select a paper to view details